A Phase 1/2 Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamis and Efficacy of VT-464 in Patients with Advanced Breast Cancer

Type of Cancer
Breast Oncology

Site
Hackensack

Sponsor
Innocrin

Protocol Number
INO-VT-464-CL-006

To Learn More Call
201-510-0910